Lancaster Kathryn E, Estadt Angela T, Enderle Madison N, Korthuis Todd P, Young April M
Department of Implementation Science, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Division of Epidemiology, College of Public Health, Ohio State University, Columbus, Ohio, USA.
J Rural Health. 2025 Jan;41(1):e70009. doi: 10.1111/jrh.70009.
Participation in clinical trials among people who use drugs (PWUD) in rural areas remains disproportionately low compared to those in urban communities. Our objective was to describe the barriers and facilitators to clinical trial participation among this understudied and underserved population.
We conducted semi-structured in-depth interviews among rural PWUD in Kentucky, Ohio, and Oregon. Using the Ickovics and Meisler framework, we classified factors associated with participation in clinical trials among rural PWUD into five categories: the individual, trial and intervention characteristics, participant-trial staff relationship, clinical trial setting, and features of the disease. We used inductive qualitative analysis methods to identify salient themes.
Thirty-five rural participants (median age: 39, 51% men) completed in-depth interviews. Facilitators for rural clinical trial participation were mainly situated within the individual, trial and intervention characteristics, and clinical trial setting. Individual characteristics, such as altruistic motivations to help their communities and peers, as well as trial and intervention characteristics like visit reminders and resource assistance, were the most frequently noted facilitators of clinical trial participation. In contrast, participation barriers were mainly related to participant-trial staff relationships and disease features. Judgmental and untrustworthy trial staff, along with involvement in the criminal legal system, were obstacles to clinical trial participation.
Individual, intrapersonal, and logistical factors described by rural PWUD must be addressed to enhance the participation and retention of this population in clinical trials. Successful clinical trial participation may contribute to equitable access to essential health services by PWUD in rural communities.
与城市社区的吸毒者相比,农村地区吸毒者参与临床试验的比例仍然极低。我们的目标是描述这一研究不足且服务欠缺人群参与临床试验的障碍和促进因素。
我们对肯塔基州、俄亥俄州和俄勒冈州的农村吸毒者进行了半结构化深度访谈。使用伊科维克斯和迈斯勒框架,我们将与农村吸毒者参与临床试验相关的因素分为五类:个人因素、试验和干预特征、参与者与试验工作人员的关系、临床试验环境以及疾病特征。我们采用归纳定性分析方法来确定突出主题。
35名农村参与者(中位年龄:39岁,51%为男性)完成了深度访谈。农村临床试验参与的促进因素主要存在于个人、试验和干预特征以及临床试验环境中。个人特征,如帮助社区和同伴的利他动机,以及试验和干预特征,如访视提醒和资源援助,是最常被提及的临床试验参与促进因素。相比之下,参与障碍主要与参与者和试验工作人员的关系以及疾病特征有关。评判性和不可信赖的试验工作人员,以及卷入刑事法律系统,是临床试验参与的障碍。
必须解决农村吸毒者所描述的个人、人际和后勤因素,以提高该人群参与临床试验并持续参与的比例。成功参与临床试验可能有助于农村社区的吸毒者公平获得基本医疗服务。